Vena cava thrombectomy and primary repair after radical nephrectomy for renal cell carcinoma: single-center experience
- PMID: 20889305
- DOI: 10.1016/j.avsg.2010.05.020
Vena cava thrombectomy and primary repair after radical nephrectomy for renal cell carcinoma: single-center experience
Abstract
Background: Inferior vena cava (IVC) reconstruction for locally advanced renal cell carcinoma (RCC) includes resection with and without interposition grafting, patch graft, or primary repair. The proposed benefits of lateral venorrhaphy and primary repair are avoidance of foreign material, a more expeditious repair, and preservation of lower extremity venous outflow.
Methods: A single-center retrospective review of 22 patients with RCC and IVC tumor thrombus treated with radical nephrectomy, lateral venorrhaphy, thrombectomy, and primary vena cava repair between July 2002 and June 2009 was carried out. Demographic data, diagnostic information, radiographic cross-sectional imaging, and procedural outcomes were examined.
Results: Among the 13 men and nine women, the mean age was 62.1 years (42-83); mean tumor size was 9.8 cm (3-17 cm), and 90% (n = 18) of the cases with RCC were identified pathologically as clear cell adenocarcinoma; on the basis of the classification system adopted by Neves, level I was for 50% (n = 11), level II for 32% (n = 7), level III for 9% (n = 2), and level IV for 9% (n = 2) of the patients. All patients underwent en bloc radical nephrectomy with tumor thrombus removal and primary IVC repair. Mean total operative time was 547.9 ± 138.5 minutes, whereas mean IVC cross-clamp time was 10.8 minutes (6-29 minutes). There were no intraoperative deaths or pulmonary embolism and all IVC margins were found to be pathologically negative. Postoperative complications included one pulmonary embolism, one exacerbation of chronic lymphedema, and two cases of new onset erectile dysfunction. Mean follow-up was 36.4 ± 23.2 months (6-92 months). There were no radiographic or clinically significant changes in mean IVC diameter during follow-up. Five late deaths (23%) occurred as a result of metastatic RCC over a mean period of 24 months (range, 12-48), but without any local recurrences.
Conclusion: For advanced RCC with tumor thrombus extension into the IVC, lateral venorrhaphy and primary IVC repair avoids complicated caval reconstructions and results in high patency rates with a low local tumor recurrence rate.
Copyright © 2011 Annals of Vascular Surgery Inc. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Long-term survival in patients undergoing radical nephrectomy and inferior vena cava thrombectomy: single-center experience.Eur Urol. 2010 Apr;57(4):667-72. doi: 10.1016/j.eururo.2009.06.009. Epub 2009 Jun 21. Eur Urol. 2010. PMID: 19560258
-
Risk factors for acute kidney injury after radical nephrectomy and inferior vena cava thrombectomy for renal cell carcinoma.J Vasc Surg. 2013 Oct;58(4):1021-7. doi: 10.1016/j.jvs.2013.02.247. Epub 2013 Apr 13. J Vasc Surg. 2013. PMID: 23591189
-
Renal cell carcinoma with inferior vena cava thrombus: the Hacettepe experience.Urol Oncol. 2010 Nov-Dec;28(6):603-9. doi: 10.1016/j.urolonc.2008.11.017. Epub 2009 Jan 26. Urol Oncol. 2010. PMID: 19171489
-
Renal cell carcinoma: vena caval involvement.BJU Int. 2007 May;99(5 Pt B):1239-44. doi: 10.1111/j.1464-410X.2007.06826.x. BJU Int. 2007. PMID: 17441917 Review. No abstract available.
-
Resection of renal tumors invading the vena cava.Urol Clin North Am. 2008 Nov;35(4):657-71; viii. doi: 10.1016/j.ucl.2008.07.013. Urol Clin North Am. 2008. PMID: 18992619 Review.
Cited by
-
Surgical treatment of renal cell carcinoma with inferior vena cava tumor thrombus.Surg Today. 2022 Aug;52(8):1125-1133. doi: 10.1007/s00595-021-02429-9. Epub 2022 Jan 3. Surg Today. 2022. PMID: 34977987 Review.
-
Resection of the inferior vena cava for urological malignancies: single-center experience.Int J Clin Oncol. 2013 Oct;18(5):905-9. doi: 10.1007/s10147-012-0473-x. Epub 2012 Sep 6. Int J Clin Oncol. 2013. PMID: 22956175
-
Patency outcomes of primary inferior vena cava repair in radical nephrectomy and tumor thrombectomy.J Vasc Surg Venous Lymphat Disord. 2023 May;11(3):595-604.e2. doi: 10.1016/j.jvsv.2023.01.004. Epub 2023 Feb 2. J Vasc Surg Venous Lymphat Disord. 2023. PMID: 36736700 Free PMC article.
-
The enduring patency of primary inferior vena cava repair.Surgery. 2017 May;161(5):1414-1422. doi: 10.1016/j.surg.2016.11.006. Epub 2016 Dec 20. Surgery. 2017. PMID: 28011005 Free PMC article.
-
ARS2/MAGL signaling in glioblastoma stem cells promotes self-renewal and M2-like polarization of tumor-associated macrophages.Nat Commun. 2020 Jun 12;11(1):2978. doi: 10.1038/s41467-020-16789-2. Nat Commun. 2020. PMID: 32532977 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials